Ayahuasca, Pain, and Inflammation: a Systematic Review of Preclinical Studies (2025)
- Authors:
- USP affiliated authors: ROSSI, GIORDANO NOVAK - FMRP ; GUERRA, LORENA TERENE LOPES - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP
- Unidade: FMRP
- DOI: 10.3390/psychoactives4030024
- Subjects: ALUCINOGÊNICOS; DOR; INFLAMAÇÃO; ANTI-INFLAMATÓRIOS
- Keywords: ayahuasca; pain; inflammation; antinociceptive; anti-inflammatory
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- ISSN: 2813-1851
- Volume/Número/Paginação/Ano: v.4, n. 3, p. 1-19, 2025
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo publicado em periódico de acesso aberto (Gold Open Access) -
ABNT
VILLANOVA, Bianca et al. Ayahuasca, Pain, and Inflammation: a Systematic Review of Preclinical Studies. v. 4, n. 3, p. 1-19, 2025Tradução . . Disponível em: https://doi.org/10.3390/psychoactives4030024. Acesso em: 14 mar. 2026. -
APA
Villanova, B., Rossi, G. N., Guerra, L. T. L., Bouso, J. C., Hallak, J. E. C., & Santos, R. G. dos. (2025). Ayahuasca, Pain, and Inflammation: a Systematic Review of Preclinical Studies, 4( 3), 1-19. doi:10.3390/psychoactives4030024 -
NLM
Villanova B, Rossi GN, Guerra LTL, Bouso JC, Hallak JEC, Santos RG dos. Ayahuasca, Pain, and Inflammation: a Systematic Review of Preclinical Studies [Internet]. 2025 ;4( 3): 1-19.[citado 2026 mar. 14 ] Available from: https://doi.org/10.3390/psychoactives4030024 -
Vancouver
Villanova B, Rossi GN, Guerra LTL, Bouso JC, Hallak JEC, Santos RG dos. Ayahuasca, Pain, and Inflammation: a Systematic Review of Preclinical Studies [Internet]. 2025 ;4( 3): 1-19.[citado 2026 mar. 14 ] Available from: https://doi.org/10.3390/psychoactives4030024 - Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant
- Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: a mechanistic overview
- The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials
- Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
- Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach
- Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: a transcultural study
- The use of classic hallucinogens/psychedelics in a therapeutic context: healthcare policy opportunities and challenges
- Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic
- Tripping to cope: coping strategies and use of hallucinogens during the COVID-19 pandemic in three cultural contexts
- Psychedelic medicines in major depression: progress and future challenges
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
